City
Epaper

RDIF seeks Sputnik M vaccine registration for adolescents in India

By IANS | Updated: December 6, 2021 22:10 IST

New Delhi, Dec 6 The Russian Direct Investment Fund (RDIF) said on Monday that it has provided documents ...

Open in App

New Delhi, Dec 6 The Russian Direct Investment Fund (RDIF) said on Monday that it has provided documents to India's regulator for the registration of Sputnik M, the vaccine for adolescents aged 12-17.

"RDIF has provided India's regulator with documents for registration of Sputnik M - the vaccine for adolescents aged 12-17. Russia's Health Ministry registered Sputnik M on November 24. It has become a new member of the Sputnik vaccines family and is offered to international markets, joining Sputnik V and Sputnik Light," the RDIF said in a statement.

"Subject to the positive decision of India's authorities, Sputnik M could become the first registered vaccine for adolescents in the country and make an important contribution in protecting the younger population," the statement added.

The Sputnik V vaccine is already being used in India after it received emergency use authorisation in April 2021. Sputnik V is the first foreign-made vaccine to be used in India.

The RDIF is also working with India's regulatory authorities for the registration of Sputnik Light, the one shot vaccine based on human adenovirus serotype 26, as a standalone vaccine and a universal booster.

Partnering Dr. Reddy's Laboratories, RDIF has conducted additional clinical trials of Sputnik Light in India. The data from these trials have been presented to the Drugs Controller General of India (DCGI).

Kirill Dmitriev, the CEO of RDIF, said, "Russia and India joined forces since the beginning of the pandemic. A number of agreements with partners in India have helped RDIF significantly increase its production capabilities. We are ready to offer the Sputnik Light vaccine and the Sputnik M vaccine for adolescents to support strong herd immunity in India and continue saving millions of lives."

The RDIF has expressed hope that Sputnik Light could be successfully applied as a booster dose in partnership with the Serum Institute of India, which already produces the two vaccines.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Russian Direct Investment FundindiaNew DelhiHealth MinistryThe new delhi municipal councilDelhi south-westIndiUk-indiaKirill dmitrievRepublic of indiaIndia india
Open in App

Related Stories

MumbaiViral Sighting of Tesla Cybertruck Near Mumbai Stirs EV Enthusiasm (Photos)

NationalPM Narendra Modi Discusses Tech and Innovation Collaboration With Elon Musk

NationalTahawwur Rana Extradition: Pakistan Distances Itself From 26/11 Accused After Arrival in India

NationalIndia Expands Rafale Power: Rs 64,000 Crore Deal Cleared for Navy Fighter Jets

NationalHeatwave in India: Maharashtra, Gujarat Experience Unbearable Night and Day Time Temperature, Bengaluru Likely to Witness Rain

Health Realted Stories

HealthStudy links antibiotic exposure before age two to childhood obesity

HealthStudy decodes how malaria can lead to childhood cancer

HealthISRO, SCTIMST sign MoU to collaborate on Space Medicine

HealthCommon diabetes drug may help manage knee arthritis, obesity

HealthLove eating chicken? Study links regular consumption with gastrointestinal cancers